These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 23023373)

  • 1. Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study.
    Røysland R; Pervez MO; Pedersen MH; Brynildsen J; Høiseth AD; Hagve TA; Røsjø H; Omland T
    PLoS One; 2016; 11(7):e0160182. PubMed ID: 27463973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of the strongest: can muscular strength measurements be used in prevention of heart failure in patients with acute coronary syndromes?
    Vistnes M
    Eur J Prev Cardiol; 2024 May; 31(7):832-833. PubMed ID: 38381591
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of circulating microRNAs in acute coronary syndromes: ready for prime time?
    Klug G; Metzler B
    Ann Transl Med; 2016 Dec; 4(24):537. PubMed ID: 28149898
    [No Abstract]   [Full Text] [Related]  

  • 4. C-reactive protein, inflammation and short-term mortality in acute heart failure.
    Cotter G; Pagnesi M; Davison B
    Eur J Heart Fail; 2024 Jun; ():. PubMed ID: 38923205
    [No Abstract]   [Full Text] [Related]  

  • 5. The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox.
    Özkalaycı F; Gülmez Ö; Uğur-Altun B; Pandi-Perumal SR; Altun A
    Balkan Med J; 2018 May; 35(3):225-232. PubMed ID: 29687784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.
    Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Hansis-Diarte A; Jenkinson C; Tripathy D; Folli F
    Acta Diabetol; 2018 Feb; 55(2):139-148. PubMed ID: 29151224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of alkaline phosphatase, osteopontin, RANK ligand and osteoprotegerin in calcified human carotid atheroma.
    Higgins CL; Isbilir S; Basto P; Chen IY; Vaduganathan M; Vaduganathan P; Reardon MJ; Lawrie G; Peterson L; Morrisett JD
    Protein J; 2015 Oct; 34(5):315-28. PubMed ID: 26307009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype.
    Holven KB; Retterstøl K; Ueland T; Ulven SM; Nenseter MS; Sandvik M; Narverud I; Berge KE; Ose L; Aukrust P; Halvorsen B
    PLoS One; 2013; 8(11):e78241. PubMed ID: 24244297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin as a marker of atherosclerosis: a systematic update.
    Hosbond SE; Poulsen TS; Diederichsen AC; Nybo M; Rasmussen LM; Mickley H
    Scand Cardiovasc J; 2012 Aug; 46(4):203-11. PubMed ID: 22506827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteoprotegerin is a new marker of cardiovascular diseases].
    Verbovoy AF; Tsanava IA; Mitroshina EV; Sharonova LA
    Ter Arkh; 2017; 89(4):91-94. PubMed ID: 28514407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes.
    Jansson AM; Hartford M; Omland T; Karlsson T; Lindmarker P; Herlitz J; Ueland T; Aukrust P; Caidahl K
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3041-9. PubMed ID: 23023373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
    Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes.
    Omland T; Ueland T; Jansson AM; Persson A; Karlsson T; Smith C; Herlitz J; Aukrust P; Hartford M; Caidahl K
    J Am Coll Cardiol; 2008 Feb; 51(6):627-33. PubMed ID: 18261681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CXCL16 and long-term outcome in acute ischemic stroke.
    Ueland T; Smedbakken LM; Hallén J; Atar D; Januzzi JL; Halvorsen B; Jensen JK; Aukrust P
    Atherosclerosis; 2012 Jan; 220(1):244-9. PubMed ID: 22055341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Pedersen S; Mogelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Sørensen TB; Iversen A; Hvelplund A; Jensen JS
    Cardiology; 2012; 123(1):31-8. PubMed ID: 22964478
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.